International Journal of Mycobacteriology

Scope & Guideline

Connecting minds to combat infectious diseases effectively.

Introduction

Immerse yourself in the scholarly insights of International Journal of Mycobacteriology with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2212-5531
PublisherWOLTERS KLUWER MEDKNOW PUBLICATIONS
Support Open AccessYes
CountryIndia
TypeJournal
Convergefrom 2012 to 2024
AbbreviationINT J MYCOBACT / Int. J. Mycobact.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressWOLTERS KLUWER INDIA PVT LTD, A-202, 2ND FLR, QUBE, C T S NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, Maharashtra 400059, INDIA

Aims and Scopes

The International Journal of Mycobacteriology focuses on advancing the understanding and management of mycobacterial diseases, particularly tuberculosis (TB) and leprosy. The journal encompasses a wide range of research areas from clinical studies to laboratory investigations, aiming to provide a comprehensive resource for researchers and healthcare professionals in the field.
  1. Clinical Research on Tuberculosis and Leprosy:
    The journal publishes extensive clinical research including epidemiological studies, treatment outcomes, and case reports that enhance the understanding of TB and leprosy in various populations.
  2. Diagnostics and Biomarkers:
    A significant focus is placed on the development and evaluation of diagnostic modalities, including molecular techniques and serological tests to improve early detection and management of mycobacterial infections.
  3. Drug Resistance and Treatment Strategies:
    The journal addresses the critical issue of drug resistance in mycobacteria, exploring new treatment regimens, pharmacogenomics, and the efficacy of existing and novel antimicrobial agents.
  4. Immunology and Pathogenesis:
    Research articles often delve into the immunological aspects of mycobacterial infections, including host-pathogen interactions, immune responses, and the role of genetic factors in susceptibility.
  5. Public Health and Policy:
    The journal contributes to public health discourse by publishing studies on the socio-economic impacts of TB and leprosy, vaccination strategies, and health policy implications.
Recent publications in the International Journal of Mycobacteriology indicate a shift towards emerging themes that reflect current global health challenges and advancements in research methodologies.
  1. Impact of COVID-19 on Mycobacterial Diseases:
    There is a growing body of research examining the interplay between COVID-19 and mycobacterial diseases, particularly how the pandemic has affected TB diagnosis, treatment, and epidemiology.
  2. Integrated Approaches to Drug-Resistant Tuberculosis:
    Research focusing on multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) is on the rise, highlighting the urgent need for innovative treatment strategies and public health interventions.
  3. Role of Genetic and Immunological Factors:
    Emerging studies are increasingly investigating the genetic polymorphisms and immunological responses that influence susceptibility to TB and leprosy, reflecting a trend towards personalized medicine.
  4. Use of Artificial Intelligence in Diagnostics:
    The application of AI and machine learning techniques in the diagnosis and management of mycobacterial infections is becoming a prominent theme, indicating a technological advancement in the field.
  5. Nontuberculous Mycobacterial Infections:
    Research on nontuberculous mycobacteria (NTM), including their clinical implications and treatment challenges, is gaining traction as these pathogens are recognized for their significance in immunocompromised patients.

Declining or Waning

While the International Journal of Mycobacteriology continues to publish a wide array of research, certain themes appear to be declining in frequency. This may reflect shifting research priorities or advancements in the field.
  1. Traditional Culture Techniques for Mycobacterial Identification:
    The reliance on conventional culture methods for identifying mycobacterial species has decreased as molecular techniques such as PCR and next-generation sequencing gain prominence due to their speed and accuracy.
  2. Basic Research on Non-Pathogenic Mycobacteria:
    Research focusing on non-pathogenic mycobacteria, while still relevant, has seen a reduction in publications as the field increasingly prioritizes pathogenic strains that have significant public health implications.
  3. Leprosy Research in Non-Endemic Regions:
    Studies specifically addressing leprosy in non-endemic areas are becoming less frequent, possibly due to a global focus on tuberculosis and the need for immediate solutions to more pressing health crises.

Similar Journals

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Unraveling Complexities in Microbial Diagnostics
Publisher: ELSEVIER SCIENCE INCISSN: 0732-8893Frequency: 12 issues/year

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, published by Elsevier Science Inc, is a leading journal in the fields of Infectious Diseases, Microbiology, and Medicine. Since its inception in 1983, this esteemed journal has consistently provided a platform for original research and comprehensive reviews that advance the understanding of diagnostic microbiology and its implications for infectious diseases. With an impressive impact factor placing it in the Q2 category in multiple relevant fields as of 2023, it stands out with Scopus rankings reinforcing its significance in academia, ranking #136 out of 344 in Infectious Diseases and #64 out of 140 in Medical Microbiology. This journal is essential for researchers, healthcare professionals, and students who seek to stay abreast of the latest developments and trends in infectious diagnostics. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE is committed to fostering excellence in research quality and academic rigor, ensuring accessibility to vital knowledge for addressing some of the most pressing health challenges of our time.

MIKROBIYOLOJI BULTENI

Exploring Innovations in Infectious Disease Research
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

Therapeutic Advances in Infectious Disease

Connecting research and practice for better patient outcomes.
Publisher: SAGE PUBLICATIONS LTDISSN: 2049-9361Frequency: 6 issues/year

Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.

Open Forum Infectious Diseases

Bridging gaps in knowledge for better health outcomes.
Publisher: OXFORD UNIV PRESS INCISSN: 2328-8957Frequency: 12 issues/year

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.

Revista Chilena de Infectologia

Connecting researchers to combat global health issues.
Publisher: SOC CHILENA INFECTOLOGIAISSN: 0716-1018Frequency: 6 issues/year

Revista Chilena de Infectologia is an esteemed academic journal dedicated to the field of infectious diseases and public health. Published by the SOC CHILENA INFECTOLOGIA, this journal has been pivotal in disseminating crucial research findings since its inception in 2000. While operating under ISSN 0716-1018 and E-ISSN 0717-6341, it aims to contribute to the understanding of both local and global health issues, particularly within the context of Chile. Currently, it holds a Q4 ranking in both the Infectious Diseases and Public Health, Environmental and Occupational Health categories as of 2023, reflecting its unique position among emerging voices in the field. The journal aspires to foster collaboration among researchers, professionals, and students by offering a platform for innovative studies and discussions that address pressing health challenges. Although it is not an Open Access journal, access options through institutional subscriptions are encouraged for a comprehensive review of its significant contributions to infectious disease research.

Southern African Journal of Infectious Diseases

Advancing research for a healthier Southern Africa.
Publisher: AOSISISSN: 2312-0053Frequency: 4 issues/year

Southern African Journal of Infectious Diseases is a pivotal platform for the dissemination and advancement of research in the field of infectious diseases, with a particular focus on issues significant to the Southern African region. Published by AOSIS, this Open Access journal has been committed to providing accessible scholarly content since 2016, enabling researchers and practitioners to stay updated with the latest developments in infectious disease epidemiology, prevention, and management. With the ISSN 2312-0053 and E-ISSN 2313-1810, the journal invites submissions that explore diverse topics, including but not limited to clinical studies, public health policies, and innovative treatment methodologies. The Southern African Journal of Infectious Diseases is an essential resource for academics, professionals, and students dedicated to combating infectious diseases and improving health outcomes in the region, fostering a collaborative approach to research and knowledge sharing.

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

Pioneering insights into microbial challenges.
Publisher: AKADEMIAI KIADO ZRTISSN: 1217-8950Frequency: 4 issues/year

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.

BMC INFECTIOUS DISEASES

Bridging gaps in infectious disease understanding.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Infectious Diseases is a premier open-access journal published by BMC in the United Kingdom, dedicated to the field of infectious diseases. Established in 2001, this journal has been at the forefront of disseminating high-quality, peer-reviewed research, contributing significantly to the global understanding of infectious pathogens and their impact on public health. With a 2023 Scopus ranking of #100 out of 344 in the Medicine - Infectious Diseases category, and a notable Q1 quartile classification, it stands as a vital resource for researchers and professionals alike. Authors benefit from the journal's broad reach and visibility, ensuring their work is accessible to a wide audience. Access options are fully open, allowing for seamless dissemination of knowledge in the ongoing battle against infectious diseases. With an established history of publishing groundbreaking studies, BMC Infectious Diseases plays a crucial role in addressing critical issues and advancing research in the ever-evolving landscape of infectious diseases.

Journal of Clinical Virology Plus

Shaping the future of virology with cutting-edge findings.
Publisher: ELSEVIERISSN: 2667-0380Frequency: 4 issues/year

The Journal of Clinical Virology Plus, published by Elsevier, is an essential resource for researchers and professionals in the fields of virology and infectious diseases. Launched in 2021, this journal aims to bridge the gap between clinical research and application, fostering a deeper understanding of viral pathogenesis, diagnostics, and therapeutic strategies. With an ISSN of 2667-0380, this open-access journal brings cutting-edge findings to the global scientific community, facilitating the rapid dissemination of knowledge critical for advancing public health. Positioned in the Q3 category for both Infectious Diseases and Virology in 2023, its ranking reflects its growing influence and relevance in the academic landscape. The journal strives to support innovative research, collaborative studies, and comprehensive reviews that address contemporary challenges in clinical virology. As it converges through the years from 2021 to 2024, Journal of Clinical Virology Plus aims to be a central hub for vital discussions and breakthroughs in this dynamic field.

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Advancing the Frontiers of Microbial Research
Publisher: ELSEVIER GMBHISSN: 1438-4221Frequency: 8 issues/year

Welcome to the International Journal of Medical Microbiology, a leading publication in the field of microbiological research and infectious diseases, offered by Elsevier GmbH. Established in 2000, this esteemed journal provides a scholarly platform for the presentation of high-quality research, reviews, and innovations that bridge medical microbiology and clinical applications. With an impressive impact factor positioning it within the Q1 category across multiple disciplines, including Infectious Diseases, Microbiology, and Medicine, the journal is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of microbial pathogenesis, diagnostics, and therapeutics. The International Journal of Medical Microbiology is committed to open access, promoting the dissemination of knowledge and accessibility for researchers, professionals, and students worldwide. Based in Munich, Germany, the journal continues to play a vital role in the global scientific community, fostering collaborations and inspiring future innovations in the fight against infectious diseases.